The Patent Finder

Estetra SRL

Also on record
Records under this name other than the patents Estetra SRL holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 25 patents it holds.

Back to Estetra SRL

PatentTitleStatus Expires Confidence
US 11,666,585Compounds and Their Uses for Alleviating Menopause-Associated Symptoms
Formerly held
In force
 · High confidence
In forceHigh confidence
US 11,452,733Compounds and Their Uses for Alleviating Menopause-Associated Symptoms
Lapsed on the fee record
Ended Sep 27, 2026 · High confidence
Lapsed on the fee recordEnded Sep 27, 2026High confidence
US 9,987,287Orally disintegrating solid dosage unit containing an estetrol component
Lapsed on the fee record
Ended Jun 5, 2026 · From the USPTO record
Lapsed on the fee recordEnded Jun 5, 2026From the USPTO record
US 9,884,064Orally disintegrating solid dosage unit containing an estetrol component
Lapsed on the fee record
Ended Feb 6, 2026 · From the USPTO record
Lapsed on the fee recordEnded Feb 6, 2026From the USPTO record
US 9,040,509Method of treating human skin and a skin care composition for use in such a method
Term ended
Term ended Jan 24, 2026 · From the USPTO record
Term endedTerm ended Jan 24, 2026From the USPTO record
US 7,871,995Drug delivery system comprising a tetrahydroxylated estrogen for use in hormonal contraception
Term ended
Term ended Oct 7, 2025 · From the USPTO record
Term endedTerm ended Oct 7, 2025From the USPTO record
US 8,048,869Pharmaceutical composition for use in hormone replacement therapy
Term ended
Term ended May 14, 2025 · From the USPTO record
Term endedTerm ended May 14, 2025From the USPTO record
US 7,943,604Method of treating human skin and a skin care composition for use in such a method
Term ended
Term ended May 1, 2025 · From the USPTO record
Term endedTerm ended May 1, 2025From the USPTO record
US 7,723,320Use of estrogen compounds to increase libido in women
Term ended
Term ended Apr 23, 2025 · From the USPTO record
Term endedTerm ended Apr 23, 2025From the USPTO record
US 10,201,611Pharmaceutical Composition Comprising Estetrol Derivatives for Use in Cancer Therapy
Term ended
Term ended Apr 11, 2025 · Low confidence
Term endedTerm ended Apr 11, 2025Low confidence
10 of 14 patents shown.
Pro members see all 14.
Pro members: see all 14 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited